1,640
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Nanophotosensitive Drugs for Light-Based Cancer Therapy: What Does the Future Hold?

, , , &
Pages 1101-1105 | Received 06 Mar 2017, Accepted 15 Mar 2017, Published online: 27 Apr 2017
 

Financial & competing interests disclosure

The authors were funded by grants from the National Institutes of Health (U54 CA199092, R01 EB021048, R01 CA171651, P50 CA094056, P30 CA091842, S10 OD016237, S10 RR031625 and S10 OD020129), Department of Defense Breast Cancer Research Program (W81XWH-16-1-0286), and the Alvin J Siteman Cancer Research Fund (11-FY16-01). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.